首页> 外文OA文献 >Pro-Apoptotic Activity of Ruxolitinib Alone and in Combination with Hydroxyurea, Busulphan, and PI3K/mTOR Inhibitors in JAK2-Positive Human Cell Lines

【2h】

Pro-Apoptotic Activity of Ruxolitinib Alone and in Combination with Hydroxyurea, Busulphan, and PI3K/mTOR Inhibitors in JAK2-Positive Human Cell Lines

机译：单独的Ruxolitinib的促凋亡活性，以及JAK2阳性人细胞系中的羟基脲，亚苏氏菌和PI3K / MTOR抑制剂组合

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Joanna Szymańska; Piotr Smolewski; Agata Majchrzak; Barbara Cebula- Obrzut; Krzysztof Chojnowski; Jacek Treliński;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells [J] . MartinelliE., TroianiT., DAiutoE., International Journal of Cancer =: Journal International du Cancer . 2013,第9期

机译：pimasertib（一种选择性的MEK 1/2抑制剂）与PI3K / mTOR抑制剂或多靶点激酶抑制剂联合在耐pimasertib的人肺癌和大肠癌细胞中的抗肿瘤活性
2. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway [J] . Ning-Kui Niu, Zi-Li Wang, Shu-Ting Pan, Drug Design, Development and Therapy . 2015,第5期

机译：Aurora激酶A抑制剂alisertib（MLN8237）通过激活线粒体介导的途径和抑制p38 MAPK / PI3K / Akt / mTOR信号传导对人骨肉瘤U-2 OS和MG-63细胞的促凋亡和促自噬作用通路
3. Combination Effect of Notch1 and PI3K / AKT / mTOR Signaling Pathways Inhibitors on T-ALL Cell Lines [J] . Halimeh Khoshamooz, Saeid Kaviani, Amir Atashi, International journal of hematology-oncology and stem cell research. . 2020,第2期

机译：Notch1和PI3K / AKT / MTOR信号传导途径抑制剂对所有细胞系的组合效应
4. Combination of PI3K/Akt/mTOR inhibitors and PDT in endothelial and tumor cells. [C] . Fateye, Babasola, Chen Bin Optical methods for tumor treatment and detection: mechanisms and techniques in photodynamic therapy XX . 2011

机译：内皮细胞和肿瘤细胞中PI3K / Akt / mTOR抑制剂和PDT的组合。
5. Clinical Pharmacokinetics of the Novel Combination of BEZ235, PI3K/mTOR Inhibitor, and Everolimus, mTOR Inhibitor: Phase I Clinical Studies and Non-Clinical Mechanistic Assessment [D] . Moorthy, Ganesh P. 2015

机译：BEZ235，PI3K / mTOR抑制剂和依维莫司，mTOR抑制剂的新型组合的临床药代动力学：I期临床研究和非临床机制评估
6. Combination Effect of Notch1 and PI3K/AKT/mTOR Signaling Pathways Inhibitors on T-ALL Cell Lines [O] . Halimeh Khoshamooz, Saeid Kaviani, Amir Atashi, 2020

机译：Notch1和PI3K / AKT / mTOR信号通路抑制剂对T-ALL细胞系的联合作用
7. Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells [O] . Martinelli Erika, Troiani Teresa, DAiuto Elena, 2013

机译：pimasertib（一种选择性的MEK 1/2抑制剂）与PI3K / mTOR抑制剂或多靶点激酶抑制剂联合在耐pimasertib的人肺癌和大肠癌细胞中的抗肿瘤活性

Pro-Apoptotic Activity of Ruxolitinib Alone and in Combination with Hydroxyurea, Busulphan, and PI3K/mTOR Inhibitors in JAK2-Positive Human Cell Lines

著录项

引文网络

相似文献

相关主题

期刊订阅